EVOK icon

Evoke Pharma
EVOK

Overview Fund Trends Analyst Outlook Journalist POV

14 hedge funds and large institutions have $3.06M invested in Evoke Pharma in 2016 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 4 increasing their positions, 1 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more capital invested

Capital invested by funds: $ → $

more funds holding

Funds holding: →

Holders
14
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$171K
2
+$129K
3
+$77.1K
4
Vanguard Group
Vanguard Group
Pennsylvania
+$19.7K
5
UBS Group
UBS Group
Switzerland
+$16K

Top Sellers

1
-$6K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$891K
2
$427K
3
$411K
4
$381K
5
$251K
6
$171K
7
$162K
8
$129K
9
$108K
10
$83K
11
$20K
12
$16K
13
$5K
14
$1K